Biosciences

All articles by Biosciences

With funding in hand, Tome Biosciences buys Replace Therapeutics for $185M
With funding in hand, Tome Biosciences buys Replace Therapeutics for $185M
Jack O'Brien
January 2, 2024
11:09 am

The Replace acquisition comes weeks after Tome Biosciences raised $213 million in funding from notable investors like Andreessen Horowitz (a16z) Bio + Health, Arch Venture Partners, Fujifilm Corporation and others.

Tome Biosciences CEO Rahul Kakkar on recent $213M funding round
Tome Biosciences CEO Rahul Kakkar on recent $213M funding round
Jack O'Brien
December 19, 2023
10:39 am

MM+M caught up with Kakkar to discuss Tome’s funding effort, the company’s efforts to build upon the progress that’s already been made with CRISPR/Cas9 technology and why the Boston biotech scene has such momentum at its back.

Gilead inks $100M partnership with Assembly Bio for antivirals
Gilead inks $100M partnership with Assembly Bio for antivirals
Lecia Bushak
October 17, 2023
3:26 pm

Gilead will pay $100 million upfront for the deal, which will involve developing therapies for herpes simplex virus and hepatitis B virus.

Genentech, Orionis Biosciences ink $47M partnership to develop molecular glues
Genentech, Orionis Biosciences ink $47M partnership to develop molecular glues
Lecia Bushak
September 20, 2023
3:39 pm

The collaboration will focus on discovering novel small molecule therapies for cancer and neurodegenerative diseases, using Orionis’ Allo-Glue platform.

Jounce renounces Redx Pharma deal, agrees to be acquired by Concentra
Jounce renounces Redx Pharma deal, agrees to be acquired by Concentra
Larry Dobrow
March 27, 2023
12:01 pm

The deal comes after Jounce’s board withdrew its recommendation to pursue a merger with Redx.

  • From Our Partners